Tag:

Profectus BioSciences

Latest Headlines

Profectus gains $6.25M in grants

October 7, 2010

Profectus BioSciences has received $6.25 million in National Institute of Allergy and Infectious Diseases grants, including $2.9 million in Small Business Innovative Research grants. The company's

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Clinical Research Associate / CRA Virology Job
Yoh - Danbury, CT, USA
Regulatory Scientist Assistant III (Senior) Job
Yoh - Kenilworth, NJ, USA
Director, Safety Pharmacology and Toxicology
Tesaro - Waltham, MA
Director, Quality
Sucampo Pharmaceuticals - Washington, DC
Analytical Scientist Job
Yoh - Durham, NC, USA

Profectus BioSciences

Latest Headlines

Latest Headlines

Profectus gains $6.25M in grants

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Profectus BioSciences

Latest Headlines

Latest Headlines

Profectus gains $6.25M in grants

Related Tags